1. Home
  2. RGEN vs LCID Comparison

RGEN vs LCID Comparison

Compare RGEN & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LCID
  • Stock Information
  • Founded
  • RGEN 1981
  • LCID 2007
  • Country
  • RGEN United States
  • LCID United States
  • Employees
  • RGEN N/A
  • LCID N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LCID Auto Manufacturing
  • Sector
  • RGEN Health Care
  • LCID Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • LCID Nasdaq
  • Market Cap
  • RGEN 8.2B
  • LCID 9.3B
  • IPO Year
  • RGEN N/A
  • LCID N/A
  • Fundamental
  • Price
  • RGEN $138.82
  • LCID $3.80
  • Analyst Decision
  • RGEN Buy
  • LCID Hold
  • Analyst Count
  • RGEN 10
  • LCID 10
  • Target Price
  • RGEN $188.38
  • LCID $3.55
  • AVG Volume (30 Days)
  • RGEN 783.2K
  • LCID 37.9M
  • Earning Date
  • RGEN 10-29-2024
  • LCID 11-05-2024
  • Dividend Yield
  • RGEN N/A
  • LCID N/A
  • EPS Growth
  • RGEN N/A
  • LCID N/A
  • EPS
  • RGEN N/A
  • LCID N/A
  • Revenue
  • RGEN $602,354,000.00
  • LCID $668,286,000.00
  • Revenue This Year
  • RGEN $0.08
  • LCID $30.88
  • Revenue Next Year
  • RGEN $12.97
  • LCID $108.70
  • P/E Ratio
  • RGEN N/A
  • LCID N/A
  • Revenue Growth
  • RGEN N/A
  • LCID N/A
  • 52 Week Low
  • RGEN $110.45
  • LCID $2.29
  • 52 Week High
  • RGEN $211.13
  • LCID $5.90
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 42.05
  • LCID 54.97
  • Support Level
  • RGEN $138.80
  • LCID $3.76
  • Resistance Level
  • RGEN $150.72
  • LCID $4.08
  • Average True Range (ATR)
  • RGEN 4.86
  • LCID 0.24
  • MACD
  • RGEN -0.95
  • LCID -0.01
  • Stochastic Oscillator
  • RGEN 12.96
  • LCID 51.91

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.

Share on Social Networks: